| [1] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版). 实用肝脏病杂志, 2018, 21:177-186.
|
| [2] |
薛芮, 范建高. 代谢相关脂肪性肝病新定义的国际专家共识简介. 实用肝脏病杂志, 2020, 23:S55-S58.
|
| [3] |
Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol, 2018, 15:11–20.
|
| [4] |
Hilscher MB, Shah VH. Small but Mighty: Platelets in NASH and Other Chronic Liver Diseases. Hepatology, 2020, 71:1501-1504.
|
| [5] |
唐承薇. 慢性肝病与血小板减少:临床处理观念的转变. 实用肝脏病杂志, 2019, 22:457-458.
|
| [6] |
Lisman T. Platelets and fibrin in progression of liver disease: friends or foes?. J Thromb Haemost, 2015, 13:54-56.
|
| [7] |
Chauhan A, Adams DH, Watson SP, et al. Platelets: No longer bystanders in liver disease. Hepatology, 2016, 64:1774-1784.
|
| [8] |
Simon TG, Henson J, Osganian S, et al. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol, 2019, 17:2776-2784.
|
| [9] |
Malehmir M, Pfister D, Gallage S, et al. Platelet GPIb alpha is a mediator and potential interventional target for NASH and subsequent liver cancer. Nat Med, 2019, 25:641-655.
|
| [10] |
Wan J, Benkdane M, Teixeira-Clerc F, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology, 2014, 59:130-142.
|
| [11] |
Hilscher MB, Sehrawat T, Arab Verdugo JP, et al. Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension. Gastroenterology, 2019, 157:193-209.
|
